Stockreport

FDA accepts Verastem's marketing application for blood cancer med duvelisib, action date October 5; shares up 33% premarket [Seeking Alpha]

Verastem, Inc.  (VSTM) 
Last verastem, inc. earnings: 10/29 04:17 pm Check Earnings Report
US:NASDAQ Investor Relations: verastem.com
PDF FDA accepts Verastem's marketing application for blood cancer med duvelisib, action date October 5; shares up 33% premarketThe FDAaccepts under Priority Review Verastem' [Read more]